Medical Research Council (MRC) · GB · UKRI
This funding opportunity supports research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), welcoming applications through any MRC funding scheme. It prioritizes research areas identified by the ME/CFS Priority Setting Partnership, including aetiology of post-exertional malaise, repurposing approved drugs, diagnostic tools, immune system role, stratification, post-infection disease, neurological symptoms, genetics, severity drivers, mitochondrial dysfunction, and oxygenation dysfunction. The scheme is open with no closing date, and funds up to 80% of full economic cost.
Eligibility follows UKRI opportunity page requirements; applicants must meet institutional and individual eligibility criteria as per UKRI guidance.
2003-05-01
Where each item on this page was read from, so every claim can be verified against the original. “Official ↗” opens the funder page the value came from; anything we could not reach or parse is listed under Not captured / obstacles below.
| Curated item | Value in this record | Source |
|---|---|---|
| Funding agency | Medical Research Council (MRC) | Official page ↗ |
| Country / funding source | GB · UKRI | Official page ↗ |
| Deadline | 2003-05-01 — read from the official page | Official page ↗ |
| Funding amount | Not stated on the official page | Official page ↗ |
| Eligibility | 2 structured dimensions — see the eligibility panel above | Official page ↗ |
Data is collected from official funder pages only. Figures are machine-curated (rule + LLM where noted) and should be re-verified on the linked source before use.